OpenCapital
Beta
Calendar
Stocks
Metrics
Connect AI
/
Stocks
Portfolio
Sign In
Toggle navigation menu
Stocks
Pfizer
Business Segments
Products & Services
Finite-lived intangible assets, period increase
Finite-lived intangible assets, period increase
Pfizer
·
Products & Services
·
2 segments
·
Rolls up to
Intangible assets, increase (decrease)
Breakdown
Segments
Tukysa
View metric
Padcev
View metric
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Tukysa
—
—
—
—
$580.00M
Padcev
$150.00M
$150.00M
$150.00M
$150.00M
—
Total
—
—
—
—
—
Padcev is derived from annual filings.